American College of Gastroenterology Annual Meeting
American College of Gastroenterology Annual Meeting
October 07, 2018
1 min watch

VIDEO: Gemelli Biotech launches IBS blood test at ACG

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

PHILADELPHIA — In this exclusive video perspective from the American College of Gastroenterology Annual Meeting, Matt Mitcho, CEO of Gemelli Biotech, talks about the company’s new partnership with Cedars-Sinai, IBS Smart.

“We’re here at ACG to launch IBS Smart, a second-generation blood test to diagnose patients with IBS-D and IBS-M,” Mitcho told Healio Gastroenterology and Liver Disease. “IBS Smart looks at levels of anti-vinculin and anti-CDTB which are important biomarkers for patients with IBS.”

Mitcho said the partnership with the Medically Associated Science and Technology Program at Cedars Sinai Medical Center allows Gemelli to get a first look at cutting edge science that comes out of the program. IBS Smart is exclusively licensed by the MAST program to Gemelli.

Disclosure: Mitcho is employed by Gemelli.